[Global approach to the treatment of small cell bronchial cancers].
320 patients were included in a trial fo chemotherapy with cyclophosphamide/adriamycin/etoposide/CCNU. A first randomization tested the effect of acetyl-salicylic acid as an anti-aggregant agent. The second randomization studied the result of maintenance chemotherapy. Patients were treated by prophylactic central nervous system irradiation. The results are analyzed according to different prognostic factors such as age, performance status, histological pattern and the center.